文献速递重症综合管理与镇静镇痛呼吸衰竭与机械通气

双肺移植受者多重耐药与超广谱β-内酰胺酶革兰阴性菌:发生率、危险因素与院内死亡率

Multidrug-Resistant and Extended-Spectrum β-Lactamase Gram-Negative Bacteria in Bilateral Lung Transplant Recipients: Incidence, Risk Factors, and In-Hospital Mortality.
PubMed 文献 · Chest · 2022-07-16
一句话结论双肺移植后30天内多重耐药/ESBL革兰阴性菌发生率为34%,院内死亡风险为对照的6.38倍,既往定植与经验性广谱抗生素暴露为独立预测因素。

该回顾性研究纳入2016年2月至2021年12月在帕多瓦大学医院ICU连续收治的132例成人首次双肺移植受者,术前均未需有创机械通气或ECMO。移植后30天内34%患者分离出多重耐药(MDR)或超广谱β-内酰胺酶(ESBL)革兰阴性菌,其中60%为临床相关感染,常见菌为铜绿假单胞菌(49%)和肺炎克雷伯菌(38%),常见部位为呼吸道(47%)和多部位(40%)。既往受者相关定植(HR 2.48,95%CI 1.04-5.90,P=.04)和经验性广谱抗生素暴露(HR 6.94,95%CI 2.93-16.46,P<.01)是独立预测因素;MDR/ESBL组院内死亡率为27%,院内死亡风险为对照的6.38倍(95%CI 1.98-20.63,P<.01)。

要点

  • 双肺移植后30天内MDR/ESBL革兰阴性菌发生率为34%(45/132),其中60%为临床相关感染。
  • MDR/ESBL组院内死亡率为27%,院内死亡风险为对照的6.38倍(HR 6.38,95%CI 1.98-20.63,P<.01)。
  • 既往受者相关定植(HR 2.48,95%CI 1.04-5.90,P=.04)和经验性广谱抗生素暴露(HR 6.94,95%CI 2.93-16.46,P<.01)是独立预测因素。
  • 最常见菌为铜绿假单胞菌(49%)和肺炎克雷伯菌(38%),最常见分离部位为呼吸道(47%)和多部位(40%)。

适用人群与场景

  • 成人首次双肺移植受者,术后收入ICU,术前未需要有创机械通气或ECMO。
  • 2016年2月至2021年12月在帕多瓦大学医院ICU连续收治的肺移植受者。

诊断标准与关键阈值

  • MDR和ESBL革兰阴性菌通过体外药敏试验鉴定,标本来自呼吸道、血液、尿液、直肠拭子或手术伤口/引流液(按常规方案)。

研究设计与关键结果

  • 研究设计:回顾性筛查连续肺移植受者,共筛查153例,132例纳入分析;中位年龄52岁(四分位距41-60岁),女性46例(35%)。
  • 主要结果:45例(34%)分离出MDR/ESBL革兰阴性菌,其中60%患者为临床相关感染;铜绿假单胞菌22例(49%),肺炎克雷伯菌17例(38%);分离部位为呼吸道21例(47%),多部位18例(40%)。
  • 独立预测因素:既往受者相关定植(HR 2.48,95%CI 1.04-5.90,P=.04)和经验性广谱抗生素暴露(HR 6.94,95%CI 2.93-16.46,P<.01)。
  • 院内死亡率:MDR/ESBL组为27%,院内死亡风险为对照的6.38倍(HR 6.38,95%CI 1.98-20.63,P<.01)。

证据类型、等级与局限

  • 证据类型:回顾性研究(原文为回顾性筛查连续肺移植受者)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对成人首次双肺移植受者,应关注既往受者相关定植和经验性广谱抗生素暴露这两个MDR/ESBL革兰阴性菌分离的临床预测因素。
  • MDR/ESBL革兰阴性菌分离与院内死亡风险升高相关(HR 6.38,95%CI 1.98-20.63,P<.01)。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: In recent decades, the incidence of multidrug-resistant (MDR) and extended-spectrum β-lactamase (ESBL) gram-negative (GN) bacteria has increased progressively among lung transplantation (LT) recipients. A prompt diagnosis, prevention, and management of these pathogens remain the cornerstone for successful organ transplantation.

RESEARCH QUESTION: What are the incidence of MDR and ESBL GN bacteria within the first 30 days after LT and related risk of in-hospital mortality? What are the potential clinical predictors of isolation of MDR and ESBL GN bacteria?

STUDY DESIGN AND METHODS: All consecutive LT recipients admitted to the ICU of the University Hospital of Padua (February 2016-December 2021) were screened retrospectively. Only adult patients undergoing the first bilateral LT and not requiring invasive mechanical ventilation, extracorporeal membrane oxygenation, or both before surgery were included. MDR and ESBL GN bacteria were identified using in vitro susceptibility tests and were isolated from the respiratory tract, blood, urine, rectal swab, or surgical wound or drainage according to a routine protocol.

RESULTS: One hundred fifty-three LT recipients were screened, and 132 were considered for analysis. Median age was 52 years (interquartile range, 41-60 years) and 46 patients (35%) were women. MDR and ESBL GN bacteria were identified in 45 patients (34%), and 60% of patients demonstrated clinically relevant infection. Pseudomonas aeruginosa (n = 22 [49%]) and Klebsiella pneumoniae (n = 17 [38%]) were frequently isolated after LT from the respiratory tract (n = 21 [47%]) and multiple sites (n = 18 [40%]). Previous recipient-related colonization (hazard ratio [HR], 2.48 [95% CI, 1.04-5.90]; P = .04) and empirical exposure to broad-spectrum antibiotics (HR, 6.94 [95% CI, 2.93-16.46]; P < .01) were independent predictors of isolation of MDR and ESBL GN bacteria. In-hospital mortality of the MDR and ESBL group was 27% (HR, 6.38 [95% CI, 1.98-20.63]; P < .01).

INTERPRETATION: The incidence of MDR and ESBL GN bacteria after LT was 34%, and in-hospital mortality was six times greater. Previous recipient-related colonization and empirical exposure to broad-spectrum antibiotics were clinical predictors of isolation of MDR and ESBL GN bacteria.

来源:Chest,查看原文。版权归原作者所有。

参考来源

  1. Boscolo A, Sella N, Pettenuzzo T, et al. Multidrug-Resistant and Extended-Spectrum β-Lactamase Gram-Negative Bacteria in Bilateral Lung Transplant Recipients: Incidence, Risk Factors, and In-Hospital Mortality. Chest. 2022. PMID: 35850288. doi:10.1016/j.chest.2022.06.046

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。